However, immune checkpoint genes including IDO1, HAVCR2, PDCD1LG2, CD274, CTLA4, and TIGIT were significantly up-regulated in tumor samples (fold change >1.30, FDR q ≤ 1.0e-5). This evidence concerns the gene PDCD1LG2 and neoplasm.